LCM
NEO icon

Legato Capital Management’s NeoGenomics NEO Stock Holding History

Legato Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-24,780
Closed -$401K – 597
2023
Q4 		$401K Buy
+24,780
New +$405K 0.05% 456
2023
Q3 		– Sell
-17,115
Closed -$275K – 608
2023
Q2 		$275K Buy
+17,115
New +$282K 0.04% 488
2021
Q3 		– Sell
-9,051
Closed -$409K – 282
2021
Q2 		$409K Buy
+9,051
New +$401K 0.06% 271

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Legato Capital Management's NEO Position: Q1 2024 in Review

Legato Capital Management sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 24,780 shares — an estimated $401K sold.

Legato Capital Management first reported a position in NEO in Q2 2021 and held it in 3 quarters. The position peaked at $409K in Q2 2021. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

  • Legato Capital Management reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
  • Legato Capital Management sold 24,780 NeoGenomics shares in Q1 2024, an estimated $401K.
  • Legato Capital Management first reported a position in NeoGenomics in Q2 2021 and held it in 3 quarters.
  • Legato Capital Management's NeoGenomics position peaked at $409K in Q2 2021.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Legato Capital Management's 13F filing for Q1 2024, filed 15 Apr 2024.